Policy
Digital Transformation
Drug Pricing
Individual Market
Medicaid
Medicare Advantage
Initiatives
MA for Tomorrow
Chronic Disease Pledge
Roadmap 2030
Research
Affordability Report
Value-Based Care
Improving Access and Outcomes
Resources
About
Board
Members
ACHP Affiliate Members
Staff
Become a Member
Sponsorship
Careers
Annual Report
ACHP Connect
Policy
Digital Transformation
Drug Pricing
Individual Market
Medicaid
Medicare Advantage
Initiatives
MA for Tomorrow
Chronic Disease Pledge
Roadmap 2030
Research
Affordability Report
Value-Based Care
Improving Access and Outcomes
Resources
About
Board
Members
ACHP Affiliate Members
Staff
Become a Member
Sponsorship
Careers
Annual Report
ACHP Connect
Ending the Allure of Drug Advertising
April 10, 2025
ACHP calls on Congress to curb direct-to-consumer (DTC) drug ad dominance. Patients should be able to access affordable, necessary medications, rather than being swayed by misleading marketing tactics.
Loading...
Taking too long?
Reload document
|
Open in new tab
Download the Infographic
New from ACHP
ACHP Recommendations for an Inferred Risk Adjustment Model
October 12, 2026
ACHP Members Lead 2027 Star Ratings and NCQA Ratings
October 9, 2026
ACHP Urges CMS to Align State Directed Payment Policy With Plans’ Financial Risk
October 8, 2026
Strengthening Medicare Advantage in 2028: ACHP Recommendations to CMS
October 8, 2026